CENTRAL VALLEY ADVISORS, LLC

Position in LLY — ELI LILLY & Co

CIK 2010698 SACRAMENTO, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$371,823

+$85,775 QoQ

Shares Held

310

-0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#3,998

of 4,605 holders

Holding Since

Mar 2024

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CENTRAL VALLEY ADVISORS, LLC holds $2,448,412 across 5 Drug Manufacturers - General names. LLY ranks #3 (15.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,091	$1,038,990
2	ABBV	AbbVie Inc.	1,883	$473,837
3	LLY	ELI LILLY & Co This page	310	$371,823
4	MRK	Merck & Co., Inc.	2,648	$340,268
5	GILD	Gilead Sciences, Inc.	1,769	$223,494

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$371,823	310	-0.3%	Shares	Sole	2026-07-22
2026-03-31	$286,048	311	+48.1%	Shares	Sole	2026-04-09
2025-12-31	$225,682	210	-33.1%	Shares	Sole	2026-01-12
2024-03-31	$244,279	314	—	Shares	Sole	2024-04-12
No filing history on record for this holder in this stock.